Ken Ofusa
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
-
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
-
- Cancer Immunotherapy and Biomarkers 2
Ken Ofusa
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 145
- Molecular Biology 222
- Infectious Diseases 33
- Immunology 29
- Oncology 36
Countries citing papers authored by Ken Ofusa
This map shows the geographic impact of Ken Ofusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Ofusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Ofusa more than expected).
Fields of papers citing papers by Ken Ofusa
This network shows the impact of papers produced by Ken Ofusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Ofusa. The network helps show where Ken Ofusa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ken Ofusa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 24 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 25 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 46 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 9 | |
| 17 | 2019 | 143 | |
| 18 | 2014 | 17 |
About Ken Ofusa
Ken Ofusa is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 18 papers that have together received 328 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (8 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cancer-related gene regulation (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (145 citations), Molecular Biology (222 citations) and Infectious Diseases (33 citations). Ken Ofusa has collaborated with scholars based in Japan, Indonesia and Denmark. Frequent co-authors include Hideshi Ishii, Hidetoshi Eguchi, Yuichiro� Doki, Masamitsu Konno, Ayumu Asai, Daisuke Motooka, Daisuke Okuzaki, Tsunekazu Mizushima, Koichi Kawamoto and Takahiro Ochiya. Their work appears in journals such as Nature Communications, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.